Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-01

FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark’s Rizatriptan Benzoate as a generic formulation for the acute treatment of migraine, representing the original generic approval for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)